Trials / Conditions / Iron Metabolism Disorders

Iron Metabolism Disorders

16 registered clinical trials studyying Iron Metabolism Disorders — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Unknown	Effect of Krill Oil Supplementation on Red Blood Cell Physiology Against Changes in Markers of Iron Metabolism NCT06151548	Poznan University of Physical Education	Phase 4
Unknown	Supplementation With Altha-aminoacids and Systemiec Inflammatory Response in Long-distance Runners. NCT05510440	Medical University of Gdansk	N/A
Recruiting	European Rare Blood Disorders Platform (ENROL) NCT06250595	Hospital Universitari Vall d'Hebron Research Institute	—
Recruiting	Study of Markers of Iron Metabolism and Their Relationship With Phosphocalcic and Hepatic Metabolism and Infla NCT05586867	Ramsay Générale de Santé	—
Recruiting	RADeep Multicenter European Epidemiological Platform for Patients Diagnosed With Rare Anemia Disorders (RADs) NCT06213402	Hospital Universitari Vall d'Hebron Research Institute	—
Completed	Inhibiting Dietary Iron Absorption in Subjects With Hereditary Hemochromatosis by a Natural Polyphenol Supplem NCT03990181	Swiss Federal Institute of Technology	N/A
Recruiting	Hepcidin and Glucose Metabolism NCT04008147	Swiss Federal Institute of Technology	N/A
Unknown	Association of Serum Ferritin and Bone Mineral Density With Bone Metabolism in Chinese Healthy Postmenopausal NCT03512743	Second Affiliated Hospital of Soochow University	—
Completed	The Effect of Genetic Variation in TMPRSS6 Gene (SNP rs855791) on Oral Iron Absorption: an Iron Stable Isotope NCT03317873	Swiss Federal Institute of Technology	N/A
Completed	Dose-escalation Trial of the Safety, Pharmacokinetics, and Pharmacodynamics of Iron Isomaltoside (Monofer®) NCT03013439	Pharmacosmos A/S	Phase 1
Completed	Iron and Muscular Damage: FEmale Metabolism and Menstrual Cycle During Exercise NCT04458662	Universidad Politecnica de Madrid	—
Unknown	Treatment of Wolfram Syndrome Type 2 With the Chelator Deferiprone and Incretin Based Therapy NCT02882477	Hadassah Medical Organization	Phase 2 / Phase 3
Completed	Iron Status in Women of Reproductive Age Reproductive Age NCT03276247	Victor Gordeuk	—
Withdrawn	Treatment of Iron Overload Requiring Chelation Therapy NCT01927913	Shire	Phase 2
Completed	Low Dose β-carotene Supplementation Diminishes Oxidative Stress in Type 2 Diabetics and Healthy Individuals NCT01477112	Instituto Venezolano de Investigaciones Cientificas	N/A
Unknown	Effects of Intravenous Injection of Erythropoietin on Hepcidin Pharmacokinetics in Healthy Volunteers NCT00687518	Rennes University Hospital	N/A